Scarica l'app Stockscreener
2.73
1.26%
-0.04
Precedente Chiudi:
$2.77
Aprire:
$2.76
Volume 24 ore:
284.69K
Relative Volume:
0.07
Capitalizzazione di mercato:
$725.28M
Reddito:
$194.75M
Utile/perdita netta:
$-51.26M
Rapporto P/E:
-9.75
EPS:
-0.28
Flusso di cassa netto:
$-23.38M
1 W Prestazione:
-7.60%
1M Prestazione:
-9.74%
6M Prestazione:
+40.26%
1 anno Prestazione:
+107.20%
Intervallo 1D:
$2.725
$2.7799
Intervallo di 1 settimana:
$2.725
$2.98
Portata 52W:
$1.24
$4.0787
Akebia Therapeutics Inc Stock (AKBA) Company Profile
Nome
Akebia Therapeutics Inc
Settore
Telefono
617-871-2098
Indirizzo
245 FIRST STREET, CAMBRIDGE, MA
Confronta AKBA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AKBA
Akebia Therapeutics Inc
|
2.7354 | 750.36M | 194.75M | -51.26M | -23.38M | -0.28 |
|
ZTS
Zoetis Inc
|
141.56 | 63.20B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.84 | 47.56B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
8.80 | 39.84B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.89 | 22.31B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
431.38 | 19.63B | 2.99B | 1.21B | 1.13B | 25.06 |
Akebia Therapeutics Inc Stock (AKBA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-04 | Ripresa | H.C. Wainwright | Buy |
| 2025-04-28 | Iniziato | Leerink Partners | Outperform |
| 2025-04-01 | Iniziato | Jefferies | Buy |
| 2023-11-29 | Ripresa | BTIG Research | Buy |
| 2023-08-28 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-05-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-03-31 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Downgrade | Mizuho | Buy → Neutral |
| 2022-03-31 | Downgrade | Needham | Buy → Hold |
| 2022-03-31 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-03-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-29 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-11-14 | Reiterato | Needham | Buy |
| 2019-08-06 | Reiterato | H.C. Wainwright | Buy |
| 2019-07-11 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-02 | Iniziato | JP Morgan | Overweight |
| 2019-03-20 | Iniziato | Citigroup | Neutral |
| 2018-09-07 | Ripresa | Morgan Stanley | Equal-Weight |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-06-06 | Reiterato | H.C. Wainwright | Buy |
| 2017-12-19 | Iniziato | Piper Jaffray | Overweight |
| 2017-12-07 | Iniziato | BTIG Research | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2017-07-10 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-27 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-27 | Reiterato | Needham | Buy |
| 2016-12-27 | Reiterato | H.C. Wainwright | Buy |
| 2016-12-20 | Reiterato | JMP Securities | Mkt Outperform |
| 2016-11-15 | Iniziato | Aegis Capital | Buy |
| 2016-09-29 | Iniziato | Brean Capital | Buy |
| 2016-03-16 | Reiterato | Needham | Buy |
| 2016-01-21 | Iniziato | Credit Suisse | Neutral |
Mostra tutto
Akebia Therapeutics Inc Borsa (AKBA) Ultime notizie
Karyopharm Therapeutics (KPTI) Moves 27.9% Higher: Will This Strength Last? - Yahoo Finance
Goldman Sachs Group Inc. Grows Stock Holdings in Akebia Therapeutics, Inc. $AKBA - MarketBeat
Market Review: Should value investors consider NRGD2025 Top Decliners & Fast Exit/Entry Strategy Plans - khodrobank.com
Options Flow: Can VIVS navigate macro headwindsMarket Performance Report & Technical Analysis for Trade Confirmation - khodrobank.com
Akebia Therapeutics extends loan agreement, receives $9.3M - MSN
Can Akebia Therapeutics Inc benefit from deglobalization2025 Biggest Moves & Risk Controlled Stock Pick Alerts - khodrobank.com
Aug Ideas: Is Akebia Therapeutics Inc attractive for institutional investorsEarnings Recap Report & Free Weekly Chart Analysis and Trade Guides - khodrobank.com
Akebia Therapeutics (NASDAQ:AKBA) Downgraded by Wall Street Zen to "Buy" - MarketBeat
Options Flow: Does Akebia Therapeutics Inc have strong fundamentalsMarket Performance Report & Consistent Income Trade Recommendations - خودرو بانک
Volume Report: What is Akebia Therapeutics Inc. s 5 year growth outlookMarket Sentiment Summary & High Conviction Investment Ideas - خودرو بانک
Trade Recap: Is Akebia Therapeutics Inc stock forming a cup and handleWeekly Trend Summary & Precise Trade Entry Recommendations - khodrobank.com
Woodline Partners LP Buys New Stake in Akebia Therapeutics, Inc. $AKBA - MarketBeat
Aug Outlook: Is Akebia Therapeutics Incs ROIC above industry averageInsider Buying & Real-Time Stock Entry Alerts - خودرو بانک
Aug Summary: Is Akebia Therapeutics Inc stock trending bullishWeekly Stock Report & Risk Controlled Daily Plans - khodrobank.com
Jobs Data: Is Akebia Therapeutics Inc forming a double bottomJuly 2025 Volume & Real-Time Market Sentiment Alerts - خودرو بانک
Exit Recap: Can Akebia Therapeutics Inc deliver consistent EPS growthPrice Action & Expert-Curated Trade Recommendations - khodrobank.com
Analyst Upgrade: Whats the beta of Akebia Therapeutics Inc stock2025 Major Catalysts & Weekly Top Gainers Trade List - خودرو بانک
Quarterly Earnings: Does ProShares Trust ProShares UltraShort Russell2000 have declining or rising EPSJuly 2025 Chart Watch & AI Based Trade Execution Alerts - خودرو بانک
What is Akebia Therapeutics Inc. s 5 year growth outlookJuly 2025 Institutional & Stepwise Trade Execution Plans - خودرو بانک
Weekly Trades: What is Fidelity National Financial Incs valuation compared to sectorShort Setup & Long-Term Safe Investment Plans - خودرو بانک
Market Leaders: Can Akebia Therapeutics Inc stock outperform in a bear market2025 Sector Review & Fast Exit and Entry Strategy Plans - خودرو بانک
Whats the beta of Akebia Therapeutics Inc stockJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - khodrobank.com
Entry Recap: Is Akebia Therapeutics Inc a stock for growth or value investorsMarket Risk Summary & Fast Entry and Exit Trade Plans - خودرو بانک
Winners Losers: Is Akebia Therapeutics Inc. a strong candidate for buy and holdInflation Watch & Weekly High Return Forecasts - خودرو بانک
Jacobs Levy Equity Management Inc. Has $3.03 Million Stake in Akebia Therapeutics, Inc. $AKBA - MarketBeat
134,277 Shares in Akebia Therapeutics, Inc. $AKBA Purchased by Alyeska Investment Group L.P. - MarketBeat
Invesco Ltd. Purchases 139,957 Shares of Akebia Therapeutics, Inc. $AKBA - MarketBeat
Individual Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Market Cap Dropped by US$50m - 富途牛牛
Retail investors who have a significant stake must be disappointed along with institutions after Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) market cap dropped by US$50m - simplywall.st
MetLife Investment Management LLC Buys 14,134 Shares of Akebia Therapeutics, Inc. $AKBA - Defense World
Akebia at H.C. Wainwright: Strategic Growth in Anemia Treatment By Investing.com - Investing.com Canada
Akebia at H.C. Wainwright: Strategic Growth in Anemia Treatment - Investing.com
Akebia Therapeutics Inc. Stock Poised for Technical ComebackWeekly Investment Recap & Free Expert Approved Momentum Trade Ideas - beatles.ru
Akebia outlines access to over 275,000 dialysis patients for Vafseo in Q4 as DaVita pilot launches - MSN
Does Akebia Therapeutics Inc. have pricing powerJuly 2025 Movers & High Accuracy Investment Entry Signals - beatles.ru
What are Akebia Therapeutics Inc.’s earnings expectationsMarket Volume Report & Consistent Income Trade Ideas - 뉴스영
Akebia Therapeutics (AKBA) Grants Stock Options to New Employees - MSN
Nantahala Capital Management LLC Invests $3.84 Million in Akebia Therapeutics, Inc. $AKBA - MarketBeat
Akebia Therapeutics, Inc. (NASDAQ:AKBA) most popular amongst individual investors who own 55% of the shares, institutions hold 43% - Yahoo Finance
Invesco Ltd. Acquires 139,957 Shares of Akebia Therapeutics, Inc. $AKBA - Defense World
How to interpret RSI for Akebia Therapeutics Inc. stockPortfolio Return Report & AI Enhanced Execution Alerts - Newser
Panic Selling: Is Akebia Therapeutics Inc. forming a bullish divergencePortfolio Gains Summary & Daily Stock Trend Watchlist - خودرو بانک
Can Akebia Therapeutics Inc. keep up with sector leadersTrade Analysis Summary & Scalable Portfolio Growth Methods - خودرو بانک
Is Akebia Therapeutics Inc. a strong candidate for buy and holdJuly 2025 Setups & Growth Oriented Trade Recommendations - خودرو بانک
Biotech Movers: Akebia Soars on Expanded Partnership With Otsuka - TheStreet
Detecting support and resistance levels for Akebia Therapeutics Inc.July 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Measuring Akebia Therapeutics Inc.’s beta against major indicesPortfolio Performance Summary & High Accuracy Buy Signal Tips - Newser
Wellington Management Group LLP Acquires 164,440 Shares of Akebia Therapeutics, Inc. $AKBA - MarketBeat
Akebia Therapeutics Inc Azioni (AKBA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):